216 related articles for article (PubMed ID: 3007554)
1. Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern.
Avgerinos PC; Schürmeyer TH; Gold PW; Tomai TP; Loriaux DL; Sherins RJ; Cutler GB; Chrousos GP
J Clin Endocrinol Metab; 1986 May; 62(5):816-21. PubMed ID: 3007554
[TBL] [Abstract][Full Text] [Related]
2. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
3. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
[TBL] [Abstract][Full Text] [Related]
5. Prolonged pulsatile administration of ovine corticotropin-releasing hormone in normal man.
Désir D; Van Cauter E; Beyloos M; Bosson D; Golstein J; Copinschi G
J Clin Endocrinol Metab; 1986 Dec; 63(6):1292-9. PubMed ID: 3023419
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men.
Avgerinos PC; Kiamouris CK; Petrakos IP; Kleanthous IK; Zorzos PA; Dimitriadis TN; Raptis SA; Cutler GB
J Clin Endocrinol Metab; 1992 Nov; 75(5):1358-61. PubMed ID: 1331166
[TBL] [Abstract][Full Text] [Related]
7. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
8. Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency.
Peterson ME; Kemppainen RJ; Orth DN
Am J Vet Res; 1992 Mar; 53(3):421-5. PubMed ID: 1317690
[TBL] [Abstract][Full Text] [Related]
9. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
10. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
[TBL] [Abstract][Full Text] [Related]
11. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
12. The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency.
Schulte HM; Chrousos GP; Avgerinos P; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1064-7. PubMed ID: 6327750
[TBL] [Abstract][Full Text] [Related]
13. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
Watanobe H; Tamura T
J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
[TBL] [Abstract][Full Text] [Related]
14. The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemia.
Goji K
Acta Endocrinol (Copenh); 1989 Mar; 120(3):390-4. PubMed ID: 2538990
[TBL] [Abstract][Full Text] [Related]
15. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
Reincke M; Allolio B; Würth G; Winkelmann W
J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
[TBL] [Abstract][Full Text] [Related]
16. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
Elias LL; Antunes-Rodrigues J; Elias PC; Moreira AC
J Clin Endocrinol Metab; 1997 Apr; 82(4):1243-7. PubMed ID: 9100602
[TBL] [Abstract][Full Text] [Related]
17. Reference ranges and factors affecting the human corticotropin-releasing hormone test in preterm, very low birth weight infants.
Ng PC; Lam CW; Lee CH; Ma KC; Fok TF; Chan IH; Wong E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4621-8. PubMed ID: 12364445
[TBL] [Abstract][Full Text] [Related]
18. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans.
Arvat E; Maccagno B; Ramunni J; Maccario M; Giordano R; Broglio F; Camanni F; Ghigo E
Eur J Endocrinol; 2000 Jul; 143(1):99-104. PubMed ID: 10870037
[TBL] [Abstract][Full Text] [Related]
19. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
[TBL] [Abstract][Full Text] [Related]
20. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
